Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Veit-Haibach

Showing results (121-130 of 220) with videos related to

Pageof 22
Sort By:
European Radiology|August 17, 2010
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT componentPatrick Veit-Haibach, Marc Schiesser, Jan Soyka, et al.
BMC Cancer|May 11, 2018
<sup>18</sup>FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort studyPaul M Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, et al.
Magnetic Resonance in Medicine|February 3, 2015
Zero TE MR bone imaging in the headFlorian Wiesinger, Laura I Sacolick, Anne Menini, et al.
Cancers|April 13, 2023
Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin's LymphomaClaudia Ortega, Yael Eshet, Anca Prica, et al.
Clinical Nuclear Medicine|December 22, 2025
Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial DiagnosisSeyed Ali Mirshahvalad, Ahmed Alghamdi, Mohammadreza Chavoshi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2020
EANM/SNMMI practice guideline for [<sup>18</sup>F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0Judit A Adam, Annika Loft, Cyrus Chargari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?Jan D Soyka, Patrick Veit-Haibach, Klaus Strobel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 25, 2007
TNM staging with FDG-PET/CT in patients with primary head and neck cancerPatrick Veit-Haibach, Christopher Luczak, Isabel Wanke, et al.
European Radiology|May 29, 2015
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparisonMarcelo A Queiroz, Rahel A Kubik-Huch, Nik Hauser, et al.
EJNMMI Research|January 24, 2014
Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CTMartin W Huellner, Timothy D Collen, Philipp Gut, et al.
Pageof 22

Showing results (121-130 of 220) with videos related to

Sort By:
Pageof 22
European Radiology|August 17, 2010
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT componentPatrick Veit-Haibach, Marc Schiesser, Jan Soyka, et al.
BMC Cancer|May 11, 2018
<sup>18</sup>FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort studyPaul M Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, et al.
Magnetic Resonance in Medicine|February 3, 2015
Zero TE MR bone imaging in the headFlorian Wiesinger, Laura I Sacolick, Anne Menini, et al.
Cancers|April 13, 2023
Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin's LymphomaClaudia Ortega, Yael Eshet, Anca Prica, et al.
Clinical Nuclear Medicine|December 22, 2025
Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial DiagnosisSeyed Ali Mirshahvalad, Ahmed Alghamdi, Mohammadreza Chavoshi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2020
EANM/SNMMI practice guideline for [<sup>18</sup>F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0Judit A Adam, Annika Loft, Cyrus Chargari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?Jan D Soyka, Patrick Veit-Haibach, Klaus Strobel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 25, 2007
TNM staging with FDG-PET/CT in patients with primary head and neck cancerPatrick Veit-Haibach, Christopher Luczak, Isabel Wanke, et al.
European Radiology|May 29, 2015
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparisonMarcelo A Queiroz, Rahel A Kubik-Huch, Nik Hauser, et al.
EJNMMI Research|January 24, 2014
Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CTMartin W Huellner, Timothy D Collen, Philipp Gut, et al.
Pageof 22